康复医学是一门相对年轻的新兴学科,是现代医学的重要组成部分.国家自然科学基金委员会（National Natural Science Foundation of China,NSFC）十分重视对康复医学基础研究的支持和引导,尤其是2009年9月成立医学科学部以来,专门设立一...康复医学是一门相对年轻的新兴学科,是现代医学的重要组成部分.国家自然科学基金委员会（National Natural Science Foundation of China,NSFC）十分重视对康复医学基础研究的支持和引导,尤其是2009年9月成立医学科学部以来,专门设立一级代码H17管理康复医学领域的项目受理和资助.现阶段国家自然科学基金（以下简称科学基金）项目指南规定：康复医学主要资助运动系统、神经系统及其他系统疾病所致功能障碍的康复机制,以及临床康复评价、治疗的科学问题研究.医学科学部自2010年开始正式受理康复医学（H17）各类基金项目申请,至2014年的5年里,共受理各类项目申请1028项,资助179项.本文就2010-2014年度科学基金康复医学领域项目受理与资助情况进行回顾.展开更多
Experimental RNA interference (RNAi) leading to the selective knockdown of gene function is induced by introducing into cells either double stranded RNA (dsRNA), or short interfering RNA (siRNA) fragments into which d...Experimental RNA interference (RNAi) leading to the selective knockdown of gene function is induced by introducing into cells either double stranded RNA (dsRNA), or short interfering RNA (siRNA) fragments into which dsRNA is cut. The siRNA triggers degradation of homologous messengerRNA (mRNA). Widely used as a research tool in the genetic model organisms Caenorhabditis elegans, Drosophila melanogaster and mouse to investigate the function of individual genes, RNAi has also been deployed in genome-wide, specific gene-knockdown screens. Recent rapid progress in the application of RNAi to mammalian cells, including neurons and muscle cells, offers new approaches to drug target identification and validation.Advances in targeted delivery of RNAi-inducing molecules have raised the possibility of using RNAi directly as a therapy for a variety of human genetic and other neural and neuromuscular disorders. Here, we review examples of the application of RNAi to worm, fly and mouse models of such diseases aimed at understanding their pathophysiology.展开更多
文摘康复医学是一门相对年轻的新兴学科,是现代医学的重要组成部分.国家自然科学基金委员会（National Natural Science Foundation of China,NSFC）十分重视对康复医学基础研究的支持和引导,尤其是2009年9月成立医学科学部以来,专门设立一级代码H17管理康复医学领域的项目受理和资助.现阶段国家自然科学基金（以下简称科学基金）项目指南规定：康复医学主要资助运动系统、神经系统及其他系统疾病所致功能障碍的康复机制,以及临床康复评价、治疗的科学问题研究.医学科学部自2010年开始正式受理康复医学（H17）各类基金项目申请,至2014年的5年里,共受理各类项目申请1028项,资助179项.本文就2010-2014年度科学基金康复医学领域项目受理与资助情况进行回顾.
文摘Experimental RNA interference (RNAi) leading to the selective knockdown of gene function is induced by introducing into cells either double stranded RNA (dsRNA), or short interfering RNA (siRNA) fragments into which dsRNA is cut. The siRNA triggers degradation of homologous messengerRNA (mRNA). Widely used as a research tool in the genetic model organisms Caenorhabditis elegans, Drosophila melanogaster and mouse to investigate the function of individual genes, RNAi has also been deployed in genome-wide, specific gene-knockdown screens. Recent rapid progress in the application of RNAi to mammalian cells, including neurons and muscle cells, offers new approaches to drug target identification and validation.Advances in targeted delivery of RNAi-inducing molecules have raised the possibility of using RNAi directly as a therapy for a variety of human genetic and other neural and neuromuscular disorders. Here, we review examples of the application of RNAi to worm, fly and mouse models of such diseases aimed at understanding their pathophysiology.
